New genetic score aims to guide Women's tough breast cancer prevention decisions
NCT ID NCT04474834
Summary
This study aims to see if providing a personalized genetic risk score helps women at high risk for breast cancer make more informed decisions about taking preventive medication. It involves 737 women who will receive their genetic risk score during a standard consultation and then be surveyed annually for 10 years. The goal is to understand if this extra genetic information influences their choices about medication, screening, and surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
-
Mayo Clinic
Scottsdale, Arizona, 85259, United States
-
Mayo Clinic
Jacksonville, Florida, 32224-9980, United States
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
-
Northwestern University
Evanston, Illinois, 60208, United States
Conditions
Explore the condition pages connected to this study.